Intrinsic value of Nevro - NVRO

Previous Close

$84.89

  Intrinsic Value

$517.89

stock screener

  Rating & Target

str. buy

+510%

  Value-price divergence*

0%

Previous close

$84.89

 
Intrinsic value

$517.89

 
Up/down potential

+510%

 
Rating

str. buy

 
Value-price divergence*

0%

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of NVRO stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2016), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 2.4

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  227.14
  60.00
  54.50
  49.55
  45.10
  41.09
  37.48
  34.23
  31.31
  28.68
  26.31
  24.18
  22.26
  20.53
  18.98
  17.58
  16.32
  15.19
  14.17
  13.26
  12.43
  11.69
  11.02
  10.42
  9.87
  9.39
  8.95
  8.55
  8.20
  7.88
  7.59
Revenue, $m
  229
  366
  566
  847
  1,228
  1,733
  2,383
  3,198
  4,199
  5,403
  6,825
  8,475
  10,361
  12,489
  14,859
  17,472
  20,324
  23,412
  26,730
  30,273
  34,036
  38,014
  42,202
  46,598
  51,199
  56,005
  61,017
  66,236
  71,666
  77,312
  83,181
Variable operating expenses, $m
 
  278
  430
  643
  934
  1,317
  1,811
  2,431
  3,191
  4,107
  5,187
  6,441
  7,875
  9,492
  11,293
  13,279
  15,446
  17,793
  20,315
  23,007
  25,867
  28,890
  32,073
  35,414
  38,911
  42,564
  46,373
  50,339
  54,466
  58,757
  63,217
Fixed operating expenses, $m
 
  83
  85
  87
  89
  92
  94
  96
  99
  101
  104
  106
  109
  112
  114
  117
  120
  123
  126
  129
  133
  136
  139
  143
  147
  150
  154
  158
  162
  166
  170
Total operating expenses, $m
  253
  361
  515
  730
  1,023
  1,409
  1,905
  2,527
  3,290
  4,208
  5,291
  6,547
  7,984
  9,604
  11,407
  13,396
  15,566
  17,916
  20,441
  23,136
  26,000
  29,026
  32,212
  35,557
  39,058
  42,714
  46,527
  50,497
  54,628
  58,923
  63,387
Operating income, $m
  -24
  5
  51
  116
  205
  324
  478
  671
  909
  1,196
  1,534
  1,928
  2,378
  2,886
  3,452
  4,076
  4,758
  5,496
  6,289
  7,136
  8,036
  8,987
  9,989
  11,041
  12,141
  13,291
  14,490
  15,739
  17,038
  18,389
  19,793
EBITDA, $m
  -22
  6
  52
  118
  209
  329
  485
  680
  921
  1,211
  1,553
  1,951
  2,407
  2,921
  3,493
  4,125
  4,814
  5,561
  6,364
  7,221
  8,131
  9,094
  10,107
  11,171
  12,285
  13,448
  14,661
  15,924
  17,239
  18,606
  20,026
Interest expense (income), $m
  2
  5
  9
  14
  22
  33
  47
  65
  87
  115
  149
  188
  234
  287
  346
  412
  485
  564
  650
  742
  841
  945
  1,056
  1,173
  1,295
  1,423
  1,557
  1,696
  1,841
  1,992
  2,149
Earnings before tax, $m
  -30
  0
  42
  102
  183
  292
  431
  606
  822
  1,080
  1,385
  1,739
  2,144
  2,599
  3,106
  3,664
  4,273
  4,932
  5,639
  6,394
  7,195
  8,042
  8,933
  9,868
  10,846
  11,868
  12,934
  14,043
  15,197
  16,397
  17,644
Tax expense, $m
  2
  0
  11
  27
  50
  79
  116
  164
  222
  292
  374
  470
  579
  702
  839
  989
  1,154
  1,332
  1,523
  1,726
  1,943
  2,171
  2,412
  2,664
  2,929
  3,204
  3,492
  3,792
  4,103
  4,427
  4,764
Net income, $m
  -32
  0
  31
  74
  134
  213
  315
  443
  600
  789
  1,011
  1,270
  1,565
  1,897
  2,267
  2,675
  3,119
  3,600
  4,116
  4,668
  5,252
  5,871
  6,521
  7,204
  7,918
  8,664
  9,441
  10,251
  11,094
  11,970
  12,880

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  276
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  431
  346
  535
  800
  1,161
  1,638
  2,252
  3,023
  3,969
  5,107
  6,451
  8,010
  9,793
  11,804
  14,045
  16,514
  19,210
  22,128
  25,265
  28,613
  32,170
  35,930
  39,888
  44,043
  48,392
  52,935
  57,672
  62,605
  67,737
  73,074
  78,621
Adjusted assets (=assets-cash), $m
  155
  346
  535
  800
  1,161
  1,638
  2,252
  3,023
  3,969
  5,107
  6,451
  8,010
  9,793
  11,804
  14,045
  16,514
  19,210
  22,128
  25,265
  28,613
  32,170
  35,930
  39,888
  44,043
  48,392
  52,935
  57,672
  62,605
  67,737
  73,074
  78,621
Revenue / Adjusted assets
  1.477
  1.058
  1.058
  1.059
  1.058
  1.058
  1.058
  1.058
  1.058
  1.058
  1.058
  1.058
  1.058
  1.058
  1.058
  1.058
  1.058
  1.058
  1.058
  1.058
  1.058
  1.058
  1.058
  1.058
  1.058
  1.058
  1.058
  1.058
  1.058
  1.058
  1.058
Average production assets, $m
  7
  10
  16
  24
  34
  49
  67
  90
  118
  151
  191
  237
  290
  350
  416
  489
  569
  656
  748
  848
  953
  1,064
  1,182
  1,305
  1,434
  1,568
  1,708
  1,855
  2,007
  2,165
  2,329
Working capital, $m
  378
  163
  252
  377
  547
  771
  1,060
  1,423
  1,869
  2,404
  3,037
  3,771
  4,611
  5,558
  6,612
  7,775
  9,044
  10,418
  11,895
  13,471
  15,146
  16,916
  18,780
  20,736
  22,784
  24,922
  27,152
  29,475
  31,891
  34,404
  37,015
Total debt, $m
  138
  247
  406
  629
  932
  1,334
  1,850
  2,498
  3,294
  4,251
  5,381
  6,693
  8,192
  9,883
  11,768
  13,845
  16,112
  18,566
  21,203
  24,020
  27,011
  30,173
  33,502
  36,996
  40,654
  44,474
  48,458
  52,607
  56,923
  61,411
  66,076
Total liabilities, $m
  182
  291
  450
  673
  976
  1,378
  1,894
  2,542
  3,338
  4,295
  5,425
  6,737
  8,236
  9,927
  11,812
  13,889
  16,156
  18,610
  21,247
  24,064
  27,055
  30,217
  33,546
  37,040
  40,698
  44,518
  48,502
  52,651
  56,967
  61,455
  66,120
Total equity, $m
  249
  55
  85
  127
  185
  260
  358
  481
  631
  812
  1,026
  1,274
  1,557
  1,877
  2,233
  2,626
  3,054
  3,518
  4,017
  4,550
  5,115
  5,713
  6,342
  7,003
  7,694
  8,417
  9,170
  9,954
  10,770
  11,619
  12,501
Total liabilities and equity, $m
  431
  346
  535
  800
  1,161
  1,638
  2,252
  3,023
  3,969
  5,107
  6,451
  8,011
  9,793
  11,804
  14,045
  16,515
  19,210
  22,128
  25,264
  28,614
  32,170
  35,930
  39,888
  44,043
  48,392
  52,935
  57,672
  62,605
  67,737
  73,074
  78,621
Debt-to-equity ratio
  0.554
  4.490
  4.770
  4.940
  5.050
  5.120
  5.170
  5.200
  5.220
  5.240
  5.250
  5.250
  5.260
  5.270
  5.270
  5.270
  5.270
  5.280
  5.280
  5.280
  5.280
  5.280
  5.280
  5.280
  5.280
  5.280
  5.280
  5.280
  5.290
  5.290
  5.290
Adjusted equity ratio
  -0.174
  0.159
  0.159
  0.159
  0.159
  0.159
  0.159
  0.159
  0.159
  0.159
  0.159
  0.159
  0.159
  0.159
  0.159
  0.159
  0.159
  0.159
  0.159
  0.159
  0.159
  0.159
  0.159
  0.159
  0.159
  0.159
  0.159
  0.159
  0.159
  0.159
  0.159

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  -32
  0
  31
  74
  134
  213
  315
  443
  600
  789
  1,011
  1,270
  1,565
  1,897
  2,267
  2,675
  3,119
  3,600
  4,116
  4,668
  5,252
  5,871
  6,521
  7,204
  7,918
  8,664
  9,441
  10,251
  11,094
  11,970
  12,880
Depreciation, amort., depletion, $m
  2
  1
  2
  2
  3
  5
  7
  9
  12
  15
  19
  24
  29
  35
  42
  49
  57
  66
  75
  85
  95
  106
  118
  130
  143
  157
  171
  185
  201
  216
  233
Funds from operations, $m
  -113
  1
  32
  77
  137
  218
  321
  452
  612
  804
  1,031
  1,293
  1,594
  1,932
  2,309
  2,724
  3,176
  3,666
  4,191
  4,752
  5,348
  5,977
  6,639
  7,334
  8,061
  8,821
  9,612
  10,437
  11,294
  12,186
  13,113
Change in working capital, $m
  -54
  61
  89
  125
  170
  225
  289
  363
  446
  536
  633
  734
  839
  947
  1,055
  1,163
  1,269
  1,374
  1,477
  1,577
  1,674
  1,770
  1,864
  1,956
  2,048
  2,139
  2,230
  2,323
  2,416
  2,513
  2,611
Cash from operations, $m
  -59
  -60
  -57
  -48
  -33
  -7
  32
  89
  166
  268
  398
  559
  754
  985
  1,254
  1,561
  1,907
  2,292
  2,715
  3,176
  3,673
  4,207
  4,775
  5,378
  6,014
  6,682
  7,382
  8,114
  8,878
  9,674
  10,502
Maintenance CAPEX, $m
  0
  -1
  -1
  -2
  -2
  -3
  -5
  -7
  -9
  -12
  -15
  -19
  -24
  -29
  -35
  -42
  -49
  -57
  -66
  -75
  -85
  -95
  -106
  -118
  -130
  -143
  -157
  -171
  -185
  -201
  -216
New CAPEX, $m
  -3
  -4
  -6
  -8
  -11
  -14
  -18
  -23
  -28
  -34
  -40
  -46
  -53
  -60
  -66
  -73
  -80
  -86
  -93
  -99
  -105
  -111
  -117
  -123
  -129
  -135
  -140
  -146
  -152
  -158
  -164
Cash from investing activities, $m
  -132
  -5
  -7
  -10
  -13
  -17
  -23
  -30
  -37
  -46
  -55
  -65
  -77
  -89
  -101
  -115
  -129
  -143
  -159
  -174
  -190
  -206
  -223
  -241
  -259
  -278
  -297
  -317
  -337
  -359
  -380
Free cash flow, $m
  -191
  -64
  -63
  -58
  -46
  -24
  9
  59
  129
  222
  343
  494
  678
  897
  1,153
  1,446
  1,778
  2,148
  2,556
  3,002
  3,483
  4,000
  4,552
  5,137
  5,754
  6,404
  7,085
  7,797
  8,540
  9,315
  10,121
Issuance/(repayment) of debt, $m
  108
  109
  159
  223
  303
  401
  516
  648
  796
  957
  1,130
  1,312
  1,500
  1,691
  1,884
  2,077
  2,267
  2,454
  2,637
  2,816
  2,991
  3,162
  3,329
  3,494
  3,658
  3,820
  3,984
  4,149
  4,316
  4,488
  4,665
Issuance/(repurchase) of shares, $m
  43
  21
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  145
  130
  159
  223
  303
  401
  516
  648
  796
  957
  1,130
  1,312
  1,500
  1,691
  1,884
  2,077
  2,267
  2,454
  2,637
  2,816
  2,991
  3,162
  3,329
  3,494
  3,658
  3,820
  3,984
  4,149
  4,316
  4,488
  4,665
Total cash flow (excl. dividends), $m
  -46
  66
  96
  165
  258
  377
  526
  708
  925
  1,180
  1,473
  1,806
  2,177
  2,588
  3,037
  3,523
  4,045
  4,603
  5,194
  5,818
  6,474
  7,162
  7,881
  8,631
  9,412
  10,224
  11,069
  11,946
  12,857
  13,803
  14,786
Retained Cash Flow (-), $m
  -14
  -21
  -30
  -42
  -57
  -76
  -98
  -123
  -150
  -181
  -214
  -248
  -284
  -320
  -356
  -393
  -429
  -464
  -499
  -532
  -565
  -598
  -629
  -661
  -692
  -722
  -753
  -784
  -816
  -849
  -882
Prev. year cash balance distribution, $m
 
  215
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  259
  66
  123
  200
  301
  428
  585
  774
  999
  1,259
  1,558
  1,894
  2,268
  2,681
  3,130
  3,617
  4,139
  4,695
  5,286
  5,909
  6,564
  7,252
  7,970
  8,720
  9,502
  10,316
  11,162
  12,041
  12,954
  13,904
Discount rate, %
 
  4.30
  4.52
  4.74
  4.98
  5.23
  5.49
  5.76
  6.05
  6.35
  6.67
  7.00
  7.35
  7.72
  8.11
  8.51
  8.94
  9.39
  9.86
  10.35
  10.87
  11.41
  11.98
  12.58
  13.21
  13.87
  14.56
  15.29
  16.05
  16.86
  17.70
PV of cash for distribution, $m
 
  249
  60
  107
  165
  233
  311
  395
  484
  574
  660
  740
  808
  862
  900
  919
  919
  901
  865
  814
  751
  679
  602
  522
  444
  370
  301
  240
  186
  141
  105
Current shareholders' claim on cash, %
  100
  94.2
  94.2
  94.2
  94.2
  94.2
  94.2
  94.2
  94.2
  94.2
  94.2
  94.2
  94.2
  94.2
  94.2
  94.2
  94.2
  94.2
  94.2
  94.2
  94.2
  94.2
  94.2
  94.2
  94.2
  94.2
  94.2
  94.2
  94.2
  94.2
  94.2

Nevro Corp., a medical device company, focuses on providing products for the patients suffering from chronic pain in the United States and internationally. It develops and commercializes the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was founded in 2006 and is headquartered in Redwood City, California.

FINANCIAL RATIOS  of  Nevro (NVRO)

Valuation Ratios
P/E Ratio -76.6
Price to Sales 10.7
Price to Book 9.8
Price to Tangible Book
Price to Cash Flow -41.6
Price to Free Cash Flow -39.6
Growth Rates
Sales Growth Rate 227.1%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -40%
Cap. Spend. - 3 Yr. Gr. Rate NaN%
Financial Strength
Quick Ratio NaN
Current Ratio 0
LT Debt to Equity 55.4%
Total Debt to Equity 55.4%
Interest Coverage -14
Management Effectiveness
Return On Assets -8.3%
Ret/ On Assets - 3 Yr. Avg. -19%
Return On Total Capital -10%
Ret/ On T. Cap. - 3 Yr. Avg. -21.3%
Return On Equity -13.2%
Return On Equity - 3 Yr. Avg. -24%
Asset Turnover 0.6
Profitability Ratios
Gross Margin 66.8%
Gross Margin - 3 Yr. Avg. 63%
EBITDA Margin -11.4%
EBITDA Margin - 3 Yr. Avg. -64.1%
Operating Margin -10.5%
Oper. Margin - 3 Yr. Avg. -61.3%
Pre-Tax Margin -13.1%
Pre-Tax Margin - 3 Yr. Avg. -66.1%
Net Profit Margin -14%
Net Profit Margin - 3 Yr. Avg. -67.9%
Effective Tax Rate -6.7%
Eff/ Tax Rate - 3 Yr. Avg. -3.8%
Payout Ratio 0%

NVRO stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the NVRO stock intrinsic value calculation we used $229 million for the last fiscal year's total revenue generated by Nevro. The default revenue input number comes from 2016 income statement of Nevro. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our NVRO stock valuation model: a) initial revenue growth rate of 60% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.3%, whose default value for NVRO is calculated based on our internal credit rating of Nevro, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Nevro.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of NVRO stock the variable cost ratio is equal to 76%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $81 million in the base year in the intrinsic value calculation for NVRO stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 3.5% for Nevro.

Corporate tax rate of 27% is the nominal tax rate for Nevro. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the NVRO stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for NVRO are equal to 2.8%.

Life of production assets of 10 years is the average useful life of capital assets used in Nevro operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for NVRO is equal to 44.5%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $249 million for Nevro - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 28.249 million for Nevro is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Nevro at the current share price and the inputted number of shares is $2.4 billion.

RELATED COMPANIES Price Int.Val. Rating
NVTR Nuvectra 11.13 1.29  str.sell
PEN Penumbra 84.00 2.16  str.sell
BSX Boston Scienti 26.89 19.06  sell
IART Integra LifeSc 50.36 21.13  str.sell

COMPANY NEWS

▶ Nevro reports 2Q loss   [Aug-08-17 12:00AM  Associated Press]
▶ Nevro Reports Second Quarter 2017 Financial Results   [Aug-07-17 04:14PM  PR Newswire]
▶ Should You Buy Nevro (NVRO) Ahead of Earnings?   [Aug-03-17 08:59AM  Zacks]
▶ ETFs with exposure to Nevro Corp. : July 7, 2017   [Jul-07-17 03:18PM  Capital Cube]
▶ Nevro (NVRO) Surges: Stock Moves 11.4% Higher   [Jul-06-17 08:48AM  Zacks]
▶ ETFs with exposure to Nevro Corp. : June 26, 2017   [Jun-26-17 04:34PM  Capital Cube]
▶ ETFs with exposure to Nevro Corp. : June 16, 2017   [Jun-16-17 04:07PM  Capital Cube]
▶ Biotech And Pharma Industry And Stock News   [May-10-17 03:02PM  Investor's Business Daily]
▶ Medtech Player Losses Double That Of Views; Shares Tumble   [04:26PM  Investor's Business Daily]
▶ Nevro reports 1Q loss   [May-08-17 04:21PM  Associated Press]
▶ Nevro Corp. Value Analysis (NYSE:NVRO) : May 1, 2017   [May-01-17 05:14PM  Capital Cube]
▶ ETFs with exposure to Nevro Corp. : April 21, 2017   [Apr-21-17 03:02PM  Capital Cube]
▶ ETFs with exposure to Nevro Corp. : April 7, 2017   [Apr-07-17 05:11PM  Capital Cube]
▶ Nevro reports 4Q loss   [04:26PM  Associated Press]
▶ ETFs with exposure to Nevro Corp. : January 25, 2017   [Jan-25-17 01:27PM  Capital Cube]
▶ Nevro Corp. Value Analysis (NYSE:NVRO) : January 11, 2017   [Jan-11-17 11:22AM  Capital Cube]
▶ Nevro Announces Filing of Lawsuit by Boston Scientific   [Dec-09-16 05:22PM  PR Newswire]
▶ Boston Scientific Hit With Patent Lawsuit (BSX, NVRO)   [Nov-29-16 04:02PM  at Investopedia]
▶ Are Investors Right To Be Bullish On Nevro Corp (NVRO)?   [Nov-23-16 12:53PM  at Insider Monkey]
▶ Nevro to Present at Upcoming Investor Conferences   [Aug-25-16 04:10PM  PR Newswire]
Stock chart of NVRO Financial statements of NVRO
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

VALUATION THEORY       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2017. All rigths reserved.